260 related articles for article (PubMed ID: 16825088)
1. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
[TBL] [Abstract][Full Text] [Related]
2. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
3. Impact of vitamin E and C supplementation on serum adhesion molecules in chronic degenerative aortic stenosis: a randomized controlled trial.
Tahir M; Foley B; Pate G; Crean P; Moore D; McCarroll N; Walsh M
Am Heart J; 2005 Aug; 150(2):302-6. PubMed ID: 16086935
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E modulation of C-reactive protein in smokers with acute coronary syndromes.
Murphy RT; Foley JB; Tome MT; Mulvihill NT; Murphy A; McCarroll N; Crean P; Walsh MJ
Free Radic Biol Med; 2004 Apr; 36(8):959-65. PubMed ID: 15059636
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of adhesion molecules in chronic kidney disease correlate with the stage of renal disease and with C-reactive protein.
Vaccaro F; Mulè G; Cottone S; Soresi M; Giannitrapani L; Vadalà A; Sparacino V; Calabrese S; Picone FP; Montalto G; Cerasola G
Arch Med Res; 2007 Jul; 38(5):534-8. PubMed ID: 17560459
[TBL] [Abstract][Full Text] [Related]
8. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
[TBL] [Abstract][Full Text] [Related]
9. Assessment of inflammatory factors and cardiac troponin T in hemodialysis patients.
Falaknazi K; Bagheri N; Taziki O
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):219-22. PubMed ID: 19237807
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
11. Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ann Nutr Metab; 2011; 58(3):197-202. PubMed ID: 21757893
[TBL] [Abstract][Full Text] [Related]
12. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients.
McIntyre C; Harper I; Macdougall IC; Raine AE; Williams A; Baker LR
Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096
[TBL] [Abstract][Full Text] [Related]
13. Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial.
Tabibi H; Hakeshzadeh F; Hedayati M; Malakoutian T
J Ren Nutr; 2011 Nov; 21(6):485-91. PubMed ID: 21439850
[TBL] [Abstract][Full Text] [Related]
14. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.
Panichi V; Taccola D; Rizza GM; Consani C; Migliori M; Filippi C; Paoletti S; Sidoti A; Borracelli D; Panicucci E; Giovannini L
J Nephrol; 2004; 17(5):715-20. PubMed ID: 15593040
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
[TBL] [Abstract][Full Text] [Related]
16. Effect of hemodiafiltration on pregnancy-associated plasma protein A (PAPP-A) and related parameters.
Kalousová M; Hodková M; Dusilová-Sulková S; Uhrová J; Tesar V; Zima T
Ren Fail; 2006; 28(8):715-21. PubMed ID: 17162432
[TBL] [Abstract][Full Text] [Related]
17. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients.
As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B
Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
19. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
[TBL] [Abstract][Full Text] [Related]
20. Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin e and intima media thickness progression in end-stage renal disease (VIPER) cohort.
Boaz M; Iuliano L; Himmelfarb J; Matas Z; Micheletta F; McMonagle E; Friedman V; Natoli S; Gvirtz G; Biro A; Smetana S; Sabo G; Gafter U; Weinstein T
Nephron Clin Pract; 2005; 100(4):c111-9. PubMed ID: 15849477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
